期刊文献+

美沙拉嗪时间依赖型结肠定位释药蜡质骨架片的制备 被引量:3

Preparation of time-dependent wax-matrix tablets for colon specific delivery system of mesalazine
在线阅读 下载PDF
导出
摘要 目的制备释药稳定的时间依赖型结肠定位释药系统。方法以蜡质材料合并羧甲基淀粉钠、氯化钠为片芯骨架,Eudragit?NE 30D为内层控释层,ACRYL-EZE为外层肠溶层制备时间依赖型结肠定位释药系统。考察蜡质材料和片芯的膨胀性及影响制剂释药时滞和释放度的主要因素,并比较含蜡质材料控释片与不含蜡质材料控释片的释放行为。结果影响制剂释药时滞及释放度的主要因素有蜡质材料、CMS-Na的用量及控释层的包衣增质量及致孔剂用量。蜡质材料熔融后体积增加(9.4±0.7)%;片芯吸水膨胀后含蜡质材料片芯厚度增加为不含蜡质片芯的1.1倍,且释放过程中也可见控释片破裂释药均在厚度方向上;含蜡质材料控释片的释药时滞较为均一,其释放相似因子为62.83±5.86,较不含蜡质材料片剂相似因子38.07±7.12高,释药速率略有减慢,但在开始释药2 h后药物能够完全释放。结论制备的蜡质骨架包衣片在模拟肠液中时滞约为2 h且释药平稳,有结肠定位释药的特性。 Objective To develop a time-dependent colon-specific tablet of mesalazine based on wax-matrix. Methods The tablet core consisted of semi-synthetic glycerides, being the wax polymeric expanding agent, CMS-Na and NaCl. The core was coated with Eudragit?NE 30D as the inner coating materials and with ACRYL-EZE as the outer coating materials. The swelling properties of wax-matrix and tablet cores, the factors which influence the release behaviors of the tablets were investigated. The release profiles of coated tablets with wax-matrix and without wax-matrix were compared. Results Some factors had great effect on drug release, including the amount of CMS-Na, wax-matrix and pore former in controlling layer, and the weight gain of controlling layer. The volume of wax-matrix after melting increased by(9.4 ± 0.7)%. After absorbing water, tablet cores swelled, and the thickness of tablet cores with wax-matrix increased to be 1.1 times of that of tablets cores without wax-matrix. The rupture for burst release of coated tablets with wax-matrix occurred in the thickness direction. Meanwhile, tablets with wax-matrix demonstrated a relatively steady lag time, a higher f2 of 62.83 ± 5.86, a slight slower release rate, and a complete release of drug within 2 h. Conclusion The wax-matrix tablets have a steady lag time and release rate, together with colon specific properties.
出处 《中国药剂学杂志(网络版)》 2014年第3期88-96,共9页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 结肠定位释药 蜡质材料 美沙拉嗪 包衣片 Pharmaceutics Colon-specific wax-matrix mesalazine coated tablet
  • 相关文献

参考文献3

  • 1程刚,肖云彩,吴寿荣,邹梅娟.新型茶碱口服结肠靶向给药系统的体内动力学[J].沈阳药科大学学报,2003,20(1):1-4. 被引量:17
  • 2Meijuan Zou,Yue Wang,Caihong Xu,Gang Cheng,Jungang Ren,Gaolei Wu.Wax-Matrix Tablet for Time-Dependent Colon-Specific Delivery System of Sophora Flavescens Aiton: Preparation and In Vivo Evaluation[J].Drug Development and Industrial Pharmacy.2009(2)
  • 3David R. Friend.New oral delivery systems for treatment of inflammatory bowel disease[J].Advanced Drug Delivery Reviews.2004(2)

二级参考文献1

  • 1肖云彩 程刚 邹梅娟.Eudragit Ne 30D 为衣材制备茶碱结肠定位释药包衣片剂的研究 [J].沈阳药科大学学报,2001,18:5-7.

共引文献16

同被引文献35

  • 1DI SABATINO A, BIANCHERI P, ROVEDATTIL, et al. Re- cent advances in understanding ulcerative colitis [ J ]. Intern Emerg Med, 2012, 7(2): 103 -111.
  • 2LAUTENSCHLAGERC, SCHMIDT C, FISCHER D, et al. Drug delivery strategies in the therapy of inflammatory bowel disease [J]. Adv Drug Deliv Rev, 2014, 71 : 58 -76.
  • 3TALAEI F, ATYABIF, AZHDARZADEH M, et al. Overcoming therapeutic obstacles in inflammatory bowel diseases: a compre- hensive review on novel drug delivery strategies[J]. Eur J Pharm Sci, 2013, 49(4) : 712 -722.
  • 4KLOTZ U. The pharmacological profile and clinical use of me- salazine ( 5-aminosalicylic acid ) [ J ]. A imittelforschung, 2012, 62(02) : 53 -58.
  • 5YANG LPH, MC CORMACK PL. MMX Mesalazine[ J]. Drugs, 2011, 71(2) : 221 -235.
  • 6DONG Y, ZHOU Z, DING H, et al. Preparation and properties of a pH sensitive carrier based on three kinds of polymer blend to control the release of 5-amino salicylic acid [ J ]. Pharm Dev Tech, 2014, 19(8): 960-967.
  • 7DAS R, PAL S. Hydroxypropyl methyl cellulose grafted with polyacrylamide: Application in controlled release of 5-amino sali- cylic acid [ J ]. Colloids Surf B Biointerfaces, 2013, 110 : 236 - 241.
  • 8KRUIS W, MEIER E, SCHUMACHER M, et al. Randomised clinical trial: mesalazine ( Salofalk granules ) for uncomplicated diverticular disease of the colon-a placebo-controlled study [ J ]. Aliment Pharmacol Ther, 2013, 37(7): 680-690.
  • 9KADIYALA I, JACOBS D. The study of marketed and experi- mental formulation approaches enabling slte-specific delivery of mesalamine in patients with inflammatory bowel disease[ J]. Re- cent Patents Drug Deliv Formul, 2014 8 (1) : 3 -11.
  • 10LOVE BL, MILLER AD. Extended-release mesalamine granules for ulcerative colitis [ J ]. Ann Pharmacother, 2012, 46 ( 11 ) : 1529 - 1536.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部